- Ottilie, S, Luth, MR, Hellemann, E, Goldgof, GM, Vigil, E, Kumar, P et al.. Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance. Commun Biol. 2022;5 (1):128. doi: 10.1038/s42003-022-03076-7. PubMed PMID:35149760 PubMed Central PMC8837787.
- Xie, SC, Metcalfe, RD, Mizutani, H, Puhalovich, T, Hanssen, E, Morton, CJ et al.. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proc Natl Acad Sci U S A. 2021;118 (39):. doi: 10.1073/pnas.2107213118. PubMed PMID:34548400 PubMed Central PMC8488693.
- Forte, B, Ottilie, S, Plater, A, Campo, B, Dechering, KJ, Gamo, FJ et al.. Prioritization of Molecular Targets for Antimalarial Drug Discovery. ACS Infect Dis. 2021;7 (10):2764-2776. doi: 10.1021/acsinfecdis.1c00322. PubMed PMID:34523908 PubMed Central PMC8608365.
- Summers, RL, Pasaje, CFA, Pisco, JP, Striepen, J, Luth, MR, Kumpornsin, K et al.. Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention. Cell Chem Biol. 2022;29 (2):191-201.e8. doi: 10.1016/j.chembiol.2021.07.010. PubMed PMID:34348113 PubMed Central PMC8878317.
- Murithi, JM, Deni, I, Pasaje, CFA, Okombo, J, Bridgford, JL, Gnädig, NF et al.. The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance. Cell Chem Biol. 2022;29 (5):824-839.e6. doi: 10.1016/j.chembiol.2021.06.006. PubMed PMID:34233174 PubMed Central PMC8727639.
Search PubMed